Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endocrine System Diseases × Paclitaxel × Clear all

Sponsor

Conditions

Breast Neoplasms 192 Carcinoma, Non-Small-Cell Lung 160 Ovarian Neoplasms 94 Lung Neoplasms 58 Fallopian Tube Neoplasms 57 Neoplasms 50 Triple Negative Breast Neoplasms 36 Neoplasm Metastasis 36 Esophageal Neoplasms 22 Carcinoma, Ovarian Epithelial 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 21 Stomach Neoplasms 20 Squamous Cell Carcinoma of Head and Neck 20 Head and Neck Neoplasms 19 Endometrial Neoplasms 19 Adenocarcinoma of Lung 17 Melanoma 15 Breast Neoplasms, Male 15 Urinary Bladder Neoplasms 13 Carcinoma 12 Uterine Cervical Neoplasms 11 Recurrence 11 Carcinoma, Squamous Cell 11 Brenner Tumor 11 Adenocarcinoma Of Esophagus 10 Small Cell Lung Carcinoma 9 Esophageal Squamous Cell Carcinoma 9 Adenocarcinoma, Bronchiolo-Alveolar 9 Prostatic Neoplasms 8 Peritoneal Neoplasms 8

Interventions

Gemcitabine 3 Albumin-Bound Paclitaxel 3 130-nm albumin-bound paclitaxel 3 selpercatinib 2 Cisplatin 2 pralsetinib 1 parathyroid hormone-related peptide (1-36) 1 napabucasin 1 Thalidomide 1 Melphalan 1 Irinotecan 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Bortezomib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡